Uncategorized
Featured Stories
DaVita Names New Leaders to Accelerate Care Transformation
DaVita Inc. to Participate in Fireside Chat with Wolfe Research
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
/C O R R E C T I O N — DaVita, Inc./
In the news release, DaVita Calls 7% Convertible Notes, Authorizes Share Repurchase, issued earlier today by DaVita, Inc. over PRNewswire, we are advised by the company that the second graph, last…
-
DaVita Calls 7% Convertible Notes, Authorizes Share Repurchase
DaVita Inc. today announced that it is calling for redemption the remainder of its 7% Convertible Subordinated Notes due 2009 (“the Notes”). The aggregate principal amount outstanding of the Notes…
-
DAVITA INC Files SEC form 8-K, Other Events and Financial Statements & Exhibits
Other Events and Financial Statements & Exhibits Item 5. Other Events and Regulation FD Disclosure Attached hereto as Exhibit 99.1 is a press release issued on August 18, 2003 announcing the…
-
DaVita Inc. Completes Partial Redemption Of 7% Convertible Subordinated Notes
DaVita Inc. today announced that it completed a call for a partial redemption of $200,000,000 principal amount of its 7% Convertible Subordinated Notes due 2009 (the “Notes”). All $200,000,000…
-
DAVITA INC Files SEC form 10-Q, Quarterly Report
Quarterly Report Results of operations Quarter ended —————————————————————————- June 30, March 31, June 30, 2003 2003 2002 ——————–…